lhc-bsa0315
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: WILSON’S DISEASE FORECAST IN 28 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
Industry Reports
Lifescience and Healthcare Market Reports
Market research reports, forecasts, and competitive analysis for Lifescience and Healthcare.
21 reports found
Page 1 of 2
lhc-bsa0314
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: PRIMARY IMMUNODEFICIENCY DISEASES FORECAST IN 23 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0313
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: PRADER–WILLI SYNDROME FORECAST IN 21 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0312
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: GROWTH HORMONE DEFICIENCY FORECAST IN 19 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0311
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: FRIEDREICH’S ATAXIA FORECAST IN 28 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0310
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: CUSHING’S SYNDROME FORECAST IN 25 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0309
$6,000
EPIOMIC EPIDEMIOLOGY SERIES: CONGENITAL ADRENAL HYPERPLASIA FORECAST IN 31 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0308
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ALPHA-1 ANTI-TRYPSIN DEFICIENCY FORECAST IN 18 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0307
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ADDISON'S DISEASE FORECAST IN 22 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0306
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: VENOUS THROMBOEMBOLISM FORECAST IN 24 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0305
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: PERIPHERAL ARTERIAL DISEASE FORECAST IN 22 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0304
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: HYPERTROPHIC CARDIOMYOPATHY FORECAST IN 26 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0303
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: HYPERTENSION FORECAST IN 19 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0302
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ATRIAL FIBRILLATION FORECAST IN 19 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0301
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: AORTIC STENOSIS FORECAST IN 25 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0300
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ANGINA PECTORIS FORECAST IN 20 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0299
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: TAY–SACHS DISEASE FORECAST IN 19 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0298
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: ONYCHOMYCOSIS FORECAST IN 22 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0297
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: MUCOPOLYSACCHARIDOSIS TYPE VI FORECAST IN 30 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics
lhc-bsa0296
$5,800
EPIOMIC EPIDEMIOLOGY SERIES: HIDRADENITIS SUPPURATIVA FORECAST IN 21 MAJOR MARKETS 2018–2028
Diagnostics and Therapeutics